p53 is frequently mutated in Barrett's metaplasia of the intestinal type

Paola Campomcnosi, Massinio Conio, Massimo Bogliolo, Stefania Urbini, Paola Assereto, Anna Aprile, Paola Monti, Hugo Aste, Gabriella Lapertosa, Alberto Inga, Angelo Abbondandolo, Gilberto Fronza

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Barrett's Esophagus (BE) is a complication of gastroesophageal reflux in which the normal squamous epithelium of the lower esophagus is replaced by metaplastic tissue. The clinical significance of this condition is the associated predisposition to adenocarcinomas (ADCs). Three types of BE have been characterized: the gastric fundic (F) type, the gastric cardial (C) type, and the intestinal (I) type. The latter is the most closely associated with the development of ADCs; the causes of this bias remain unknown. To determine whether p53 and/or K-ras gene alterations (a) are present in preneoplastic lesions and (b) are associated with a specific histotype, we performed PCR-based denaturing gradient gel electrophoresis (DGGE) analysis of exon 1 (codons 12-13) of K-ras gene and of exons 5-8 of the p53 gene in biopsies obtained from 30 patients with BE of the I type 19 patients), combined I type (I + C ± F; 10 patients) and non-I type (C, F, or C + F; 11 patients). None of the cases under study revealed K-ras mutations, whereas biopsies from 12 patients showed at least one p55 DGGE variant. Four patients showed the exact same variants in leukocytes also (polymorphisms), whereas eight cases revealed specific DGGE variants only in biopsies. The molecular characterization of these variants revealed that four of them showed a single base pair substitution, and four showed multiple mutations. Of 17 somatic mutations, all but 1 were base pair substitutions located mainly in exons 7 and 8. The majority of these mutations were GC targeted (13 of 16; 81%), 54% (7 of 13) of which were transitions occurring at CpG sites. All somatic mutations were found in BE with at least one 1 component. The association with the histotype was statistically significant (P <0.03; pure 1 type versus non-I type; P <0.04, combined I type versus non-I type; Fisher's exact test). Loss of heterozygosity in the vicinity of the p53 locus was evaluated by PCR using a highly polymorphic variable number of tandem repeats marker on 25 out of 30 cases. Ninety-two % of the cases analyzed were informative, and none of them showed LOH. In conclusion, we showed that p53 mutations are frequently observed in specimens from BE patients of the I- type, whereas no involvement of K-ras (exon 1) mutational activation was observed. In light of the key roles that the p53 protein plays in controlling cell cycle and cell diploidy, this result may suggest why this type of metaplasia is the most closely associated to the development of ADCs.

Original languageEnglish
Pages (from-to)559-565
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume5
Issue number7
Publication statusPublished - Jul 1996

Fingerprint

Barrett Esophagus
Denaturing Gradient Gel Electrophoresis
Mutation
Exons
Adenocarcinoma
ras Genes
Biopsy
Base Pairing
Stomach
Polymerase Chain Reaction
Minisatellite Repeats
Loss of Heterozygosity
p53 Genes
Metaplasia
Gastroesophageal Reflux
Diploidy
Codon
Esophagus
Cell Cycle
Leukocytes

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Campomcnosi, P., Conio, M., Bogliolo, M., Urbini, S., Assereto, P., Aprile, A., ... Fronza, G. (1996). p53 is frequently mutated in Barrett's metaplasia of the intestinal type. Cancer Epidemiology Biomarkers and Prevention, 5(7), 559-565.

p53 is frequently mutated in Barrett's metaplasia of the intestinal type. / Campomcnosi, Paola; Conio, Massinio; Bogliolo, Massimo; Urbini, Stefania; Assereto, Paola; Aprile, Anna; Monti, Paola; Aste, Hugo; Lapertosa, Gabriella; Inga, Alberto; Abbondandolo, Angelo; Fronza, Gilberto.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 5, No. 7, 07.1996, p. 559-565.

Research output: Contribution to journalArticle

Campomcnosi, P, Conio, M, Bogliolo, M, Urbini, S, Assereto, P, Aprile, A, Monti, P, Aste, H, Lapertosa, G, Inga, A, Abbondandolo, A & Fronza, G 1996, 'p53 is frequently mutated in Barrett's metaplasia of the intestinal type', Cancer Epidemiology Biomarkers and Prevention, vol. 5, no. 7, pp. 559-565.
Campomcnosi P, Conio M, Bogliolo M, Urbini S, Assereto P, Aprile A et al. p53 is frequently mutated in Barrett's metaplasia of the intestinal type. Cancer Epidemiology Biomarkers and Prevention. 1996 Jul;5(7):559-565.
Campomcnosi, Paola ; Conio, Massinio ; Bogliolo, Massimo ; Urbini, Stefania ; Assereto, Paola ; Aprile, Anna ; Monti, Paola ; Aste, Hugo ; Lapertosa, Gabriella ; Inga, Alberto ; Abbondandolo, Angelo ; Fronza, Gilberto. / p53 is frequently mutated in Barrett's metaplasia of the intestinal type. In: Cancer Epidemiology Biomarkers and Prevention. 1996 ; Vol. 5, No. 7. pp. 559-565.
@article{1b06603442494df4b98d56f0f44348c3,
title = "p53 is frequently mutated in Barrett's metaplasia of the intestinal type",
abstract = "Barrett's Esophagus (BE) is a complication of gastroesophageal reflux in which the normal squamous epithelium of the lower esophagus is replaced by metaplastic tissue. The clinical significance of this condition is the associated predisposition to adenocarcinomas (ADCs). Three types of BE have been characterized: the gastric fundic (F) type, the gastric cardial (C) type, and the intestinal (I) type. The latter is the most closely associated with the development of ADCs; the causes of this bias remain unknown. To determine whether p53 and/or K-ras gene alterations (a) are present in preneoplastic lesions and (b) are associated with a specific histotype, we performed PCR-based denaturing gradient gel electrophoresis (DGGE) analysis of exon 1 (codons 12-13) of K-ras gene and of exons 5-8 of the p53 gene in biopsies obtained from 30 patients with BE of the I type 19 patients), combined I type (I + C ± F; 10 patients) and non-I type (C, F, or C + F; 11 patients). None of the cases under study revealed K-ras mutations, whereas biopsies from 12 patients showed at least one p55 DGGE variant. Four patients showed the exact same variants in leukocytes also (polymorphisms), whereas eight cases revealed specific DGGE variants only in biopsies. The molecular characterization of these variants revealed that four of them showed a single base pair substitution, and four showed multiple mutations. Of 17 somatic mutations, all but 1 were base pair substitutions located mainly in exons 7 and 8. The majority of these mutations were GC targeted (13 of 16; 81{\%}), 54{\%} (7 of 13) of which were transitions occurring at CpG sites. All somatic mutations were found in BE with at least one 1 component. The association with the histotype was statistically significant (P <0.03; pure 1 type versus non-I type; P <0.04, combined I type versus non-I type; Fisher's exact test). Loss of heterozygosity in the vicinity of the p53 locus was evaluated by PCR using a highly polymorphic variable number of tandem repeats marker on 25 out of 30 cases. Ninety-two {\%} of the cases analyzed were informative, and none of them showed LOH. In conclusion, we showed that p53 mutations are frequently observed in specimens from BE patients of the I- type, whereas no involvement of K-ras (exon 1) mutational activation was observed. In light of the key roles that the p53 protein plays in controlling cell cycle and cell diploidy, this result may suggest why this type of metaplasia is the most closely associated to the development of ADCs.",
author = "Paola Campomcnosi and Massinio Conio and Massimo Bogliolo and Stefania Urbini and Paola Assereto and Anna Aprile and Paola Monti and Hugo Aste and Gabriella Lapertosa and Alberto Inga and Angelo Abbondandolo and Gilberto Fronza",
year = "1996",
month = "7",
language = "English",
volume = "5",
pages = "559--565",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - p53 is frequently mutated in Barrett's metaplasia of the intestinal type

AU - Campomcnosi, Paola

AU - Conio, Massinio

AU - Bogliolo, Massimo

AU - Urbini, Stefania

AU - Assereto, Paola

AU - Aprile, Anna

AU - Monti, Paola

AU - Aste, Hugo

AU - Lapertosa, Gabriella

AU - Inga, Alberto

AU - Abbondandolo, Angelo

AU - Fronza, Gilberto

PY - 1996/7

Y1 - 1996/7

N2 - Barrett's Esophagus (BE) is a complication of gastroesophageal reflux in which the normal squamous epithelium of the lower esophagus is replaced by metaplastic tissue. The clinical significance of this condition is the associated predisposition to adenocarcinomas (ADCs). Three types of BE have been characterized: the gastric fundic (F) type, the gastric cardial (C) type, and the intestinal (I) type. The latter is the most closely associated with the development of ADCs; the causes of this bias remain unknown. To determine whether p53 and/or K-ras gene alterations (a) are present in preneoplastic lesions and (b) are associated with a specific histotype, we performed PCR-based denaturing gradient gel electrophoresis (DGGE) analysis of exon 1 (codons 12-13) of K-ras gene and of exons 5-8 of the p53 gene in biopsies obtained from 30 patients with BE of the I type 19 patients), combined I type (I + C ± F; 10 patients) and non-I type (C, F, or C + F; 11 patients). None of the cases under study revealed K-ras mutations, whereas biopsies from 12 patients showed at least one p55 DGGE variant. Four patients showed the exact same variants in leukocytes also (polymorphisms), whereas eight cases revealed specific DGGE variants only in biopsies. The molecular characterization of these variants revealed that four of them showed a single base pair substitution, and four showed multiple mutations. Of 17 somatic mutations, all but 1 were base pair substitutions located mainly in exons 7 and 8. The majority of these mutations were GC targeted (13 of 16; 81%), 54% (7 of 13) of which were transitions occurring at CpG sites. All somatic mutations were found in BE with at least one 1 component. The association with the histotype was statistically significant (P <0.03; pure 1 type versus non-I type; P <0.04, combined I type versus non-I type; Fisher's exact test). Loss of heterozygosity in the vicinity of the p53 locus was evaluated by PCR using a highly polymorphic variable number of tandem repeats marker on 25 out of 30 cases. Ninety-two % of the cases analyzed were informative, and none of them showed LOH. In conclusion, we showed that p53 mutations are frequently observed in specimens from BE patients of the I- type, whereas no involvement of K-ras (exon 1) mutational activation was observed. In light of the key roles that the p53 protein plays in controlling cell cycle and cell diploidy, this result may suggest why this type of metaplasia is the most closely associated to the development of ADCs.

AB - Barrett's Esophagus (BE) is a complication of gastroesophageal reflux in which the normal squamous epithelium of the lower esophagus is replaced by metaplastic tissue. The clinical significance of this condition is the associated predisposition to adenocarcinomas (ADCs). Three types of BE have been characterized: the gastric fundic (F) type, the gastric cardial (C) type, and the intestinal (I) type. The latter is the most closely associated with the development of ADCs; the causes of this bias remain unknown. To determine whether p53 and/or K-ras gene alterations (a) are present in preneoplastic lesions and (b) are associated with a specific histotype, we performed PCR-based denaturing gradient gel electrophoresis (DGGE) analysis of exon 1 (codons 12-13) of K-ras gene and of exons 5-8 of the p53 gene in biopsies obtained from 30 patients with BE of the I type 19 patients), combined I type (I + C ± F; 10 patients) and non-I type (C, F, or C + F; 11 patients). None of the cases under study revealed K-ras mutations, whereas biopsies from 12 patients showed at least one p55 DGGE variant. Four patients showed the exact same variants in leukocytes also (polymorphisms), whereas eight cases revealed specific DGGE variants only in biopsies. The molecular characterization of these variants revealed that four of them showed a single base pair substitution, and four showed multiple mutations. Of 17 somatic mutations, all but 1 were base pair substitutions located mainly in exons 7 and 8. The majority of these mutations were GC targeted (13 of 16; 81%), 54% (7 of 13) of which were transitions occurring at CpG sites. All somatic mutations were found in BE with at least one 1 component. The association with the histotype was statistically significant (P <0.03; pure 1 type versus non-I type; P <0.04, combined I type versus non-I type; Fisher's exact test). Loss of heterozygosity in the vicinity of the p53 locus was evaluated by PCR using a highly polymorphic variable number of tandem repeats marker on 25 out of 30 cases. Ninety-two % of the cases analyzed were informative, and none of them showed LOH. In conclusion, we showed that p53 mutations are frequently observed in specimens from BE patients of the I- type, whereas no involvement of K-ras (exon 1) mutational activation was observed. In light of the key roles that the p53 protein plays in controlling cell cycle and cell diploidy, this result may suggest why this type of metaplasia is the most closely associated to the development of ADCs.

UR - http://www.scopus.com/inward/record.url?scp=15844401784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15844401784&partnerID=8YFLogxK

M3 - Article

C2 - 8827361

AN - SCOPUS:15844401784

VL - 5

SP - 559

EP - 565

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 7

ER -